Ludwig Institute for Cancer Research Limited

Lan-Qing Huang

Etienne De Plaen

Aline Van Pel

Francis Brasseur

Thierry R Boon-Falleur

Thierry Boon

Polypeptides comprising an unbroken sequence of amino acids from SEQ. ID. NO. 1 or 2, with an ability to complex with a major histocompatibility complex molecule type HLA-A2, and preferably HLA-A2.1.

Tumour rejection antigens

Polypeptides comprising an unbroken sequence of amino acids from SEQ ID NO: 1 or 2, with an ability to complex with a major histocompatibility complex molecule type HLA-A2, and preferably HLA-A2.1.

Growing community of inventors

Baltimore, MD, United States of America

Lan-Qing Huang